Clinical trials
Completed Phase 3 trials in Nepal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Population Health Research Institute | 3 |
| Tribhuvan University Teaching Hospital, Institute Of Medicine. | 3 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Johns Hopkins Bloomberg School of Public Health | 2 |
| B.P. Koirala Institute of Health Sciences | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| International Vaccine Institute | 1 |
| Jiangsu Rec-Biotechnology Co., Ltd. | 1 |
| KIST Medical and Teaching Hospital | 1 |
| Oxford University Clinical Research Unit, Vietnam | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 4 |
| Pneumonia | 2 |
| Atrial Fibrillation | 1 |
| Burns | 1 |
| Cardiovascular Diseases | 1 |
| Cholera | 1 |
| Corneal Ulcer | 1 |
| Coronavirus Infections | 1 |
| Eye Diseases | 1 |
| Eye Infections, Fungal | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.